|
Company Profile
Our Story
ScienceBased Health (SBH) develops evidence-based nutraceuticals specialized in eye health. The company was founded in 1997 by a group of forward-thinking ophthalmologists and optometrists who discovered an overwhelming level of consumer interest in
wellness and prevention, a great deal of confusion in the marketplace, and
increasing clinical evidence supporting the role of nutrition in promoting good health and well-being. As many were looking to their doctors for guidance in the area of prevention and wellness, SBH focused on supporting eyecare practitioners with credible information and scientifically sound nutritional products that they confidently recommend to their patients. Since its founding, SBH has been committed to enhancing the level of patient care through product innovation, leadership, education and support.
SBH distributes its nutritional formulations through thousands of recommending ophthalmologists and optometrists. The products are available through eyecare professionals or directly through SBH.
Science Doesn’t Stand Still and Neither Do We
SBH regularly analyzes emerging research on nutrition’s role in eye and body health and swiftly updates its formulations when warranted by the strength of the science. The merits of new research and formulation updates are carefully considered by the Company’s team of nutrition scientists, researchers and Scientific Advisory Board members, comprised of leaders in the fields of ophthalmology and nutrition. SBH products always reflect the most current scientific research.
Over the years, we have seen exciting nutrition research open new avenues of treatment in eye care, and this is only the beginning. We look forward to bringing future developments in nutrition and visual health to our customers.
Our Quality Standards
SBH products are manufactured in state-of-the-art U.S. facilities that meet or exceed the new GMPs (Good Manufacturing Practices) that govern the ways in which dietary supplements are manufactured. SBH products utilize pharmaceutical grade ingredients, wherever available, and include meaningful levels of key nutrients. The formulations are not sold in retail stores. Rather, they are shipped fresh directly to customers shortly after being manufactured. Learn more
The New Standard of Care in Medicine
In 2001, The AREDS clinical trial, supported by the National Eye Institute, was published in the October issue of Archives of Ophthalmology. The AREDS trial showed that patients with Age-Related Macular Degeneration (AMD) could significantly slow the progression of their vision loss by taking an antioxidant and zinc supplement. The use of an AREDS-based nutritional supplement has now become an important component of mainstream treatment for those with AMD. We are learning that the AREDS findings are just the tip of the iceberg, as hundreds of new research studies over the years continue to show health benefits of other key nutrients. The AREDS 2 clinical trial now provides added validation for the use of nutrients such as lutein, zeaxanthin, and other antioxidants for protecting visual health.
Product Overview
The Company's proprietary formulations include HydroEye®, a unique, patented, oral nutritional supplement for dry eye;
OcularProtect®, a comprehensive multinutrient formula for eyes and overall body health; MacularProtect Complete® and
MaculartProtect Complete®-S, convenient, all-in-one formulations for macular and whole body health based on the AREDS clinical trial;
OmegaAdvance® an advanced omega-3 fish oil supplement with lutein and olive leaf extract for macular and whole body
health; Optic Nerve Formula®, a specialized formulation with phytonutrients and fatty acids, designed to protect the
optic nerve; DiaVis®, nutritional support for Diabetes and whole body health; and other high quality products to support eye health.
Learn more about our products »
SBH's advisory boards play important roles in product development, scientific review, education, and other key areas. Our Scientific Advisory Board reviews scientific developments in nutrition and eye health, and work closely with SBH's nutrition scientists in updating SBH's formulations and in developing new products. Our Optometric Advisory Board advises SBH on key issues relevant to optometry, eyecare patients and optometric practice, and helps educate fellow doctors and patients on the importance of nutrition in eye care.
Choose a link below to view information on our advisory board members:
SBH Scientific Advisory Board

Paul S. Bernstein, MD, PhD
|
|
Paul S. Bernstein, MD, PhD is a tenured Associate Professor of Ophthalmology and Visual Sciences in the Retina Division
at the Moran Eye Center, University of Utah School of Medicine. Dr. Bernstein graduated summa cum laude from
Harvard University, where he also received his MD and PhD in pharmacology. After interning at New England Deaconess
Hospital, he completed an Ophthalmology residency and a fellowship in retinal cell biology at the Jules Stein Eye
Institute of UCLA School of Medicine, followed by a fellowship in vitreoretinal surgery and research at the
Massachusetts Eye and Ear Infirmary. During his residency in Ophthalmology at Jules Stein, he was a recipient of the
Jules Stein Resident Research Award. Long interested in macular pigments, Dr. Bernstein has pioneered a method for
measuring carotenoid pigment levels. Along with his colleagues, he holds several patents on the non-invasive resonance
Raman imaging method for quantifying pigments in the living human macula, and has authored numerous papers on that topic.
In addition, Dr. Bernstein's interests include the ocular effects of oxidative stress, and the relationships between
dietary carotenoid intake, optical density of the macula and the risk of age-related macular degeneration. Dr. Bernstein
is the recipient of numerous awards and grants, and is extensively published.
View / Listen to an interview with Paul Bernstein, MD, PhD on the Role of Lutein & zeaxanthin in Macular Health
|

Jeffrey B. Blumberg PhD, FACN, FASN, CNS
|
|
Jeffrey Blumberg received Bachelor of Science degrees in Pharmacy and Psychology from Washington State University and a PhD in Pharmacology from Vanderbilt University School of Medicine. He also received postdoctoral training in cyclic nucleotide metabolism at the Tennessee Neuropsychiatric Institute and the University of Calgary. Dr. Blumberg is a Professor in the Friedman School of Nutrition Science and Policy and also serves as the Director of the Antioxidants Research Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. His research has focused on the biochemical basis for the role of antioxidant nutrients and their dietary requirements in promoting health and preventing disease during the aging process via changes in status of oxidative stress and inflammation. He has published more than 300 scientific articles and serves on the editorial boards of several scientific journals. Dr. Blumberg also participates in activities relevant to the incorporation of sound nutrition science into public health policy and has served as a member of the Surgeon General's Workshop on Health Promotion and Aging, Sports Medicine Committee of the U.S. Olympic Committee, WHO/FAO Consultation on Preparation and Use of Food-Based Dietary Guidelines, Food Advisory Committee of the FDA, and other committees.
|

Alon Harris, MS, PhD, FARVO
|
|
Alon Harris, PhD is the Lois Letzter-Endowed Professor of Ophthalmology and a Professor of Cellular & Integrative Physiology at the Indiana University School of Medicine in Indianapolis. Dr. Harris received his doctorate degree at Indiana University, Bloomington, and did postgraduate work in physiology and biophysics at that institution. He is the co-founder of the Glaucoma Research and Diagnostic Center, where he heads a multi-disciplinary team that conducts state-of-the-art studies focusing on the role of IOP and ischemia in glaucoma progression, glaucoma prevalence and incidence. He is also Director, Clinical Research, at the Eugene and Marilyn Glick Eye Institute. Professor Harris has spearheaded studies on ocular blood flow for over 20 years, and is one of the principal investigators in The Thessaloniki Eye Study – one of the largest population-based studies in ophthalmology. He has authored more than 250 journal articles, and is the recipient of numerous awards including the Edmund Benjamin Spaeth Oration Award for Outstanding Clinical Research and the William and Mary Greve International Research Scholar Award from the Research to Prevent Blindness organization. Dr. Harris co-chaired the World Glaucoma Congress Consensus on Ocular Blood Flow, is a member of the Executive Committee of the International Glaucoma Society, and serves on the editorial board of several journals.
|

Douglas D. Koch, MD
|
|
Dr. Koch is a Professor and The Allen, Mosbacher, and Law Chair in Ophthalmology at the Cullen Eye Institute, Baylor
College of Medicine. He is the Editor of the Journal of Cataract and Refractive Surgery, Past President of the American
Society of Cataract and Refractive Surgery, and Past President of the International Intra-Ocular Implant Club. He has
authored over 100 articles and book chapters on the topics of cataract and refractive surgery. He has given several named
lectureships, including the Binkhorst Lecture at the American Academy of Ophthalmology Annual Meeting, the Lans Lecture
at the International Society of Refractive Surgery Annual Meeting, the Ronald G. Michels Memorial Lecture at Johns
Hopkins University, the Jules Stein Lecture at UCLA, and the First Gold Medal Lecture, at the Australian Society of
Cataract and Refractive Surgery in Queensland, Australia. Dr. Koch was named as one of the top 10 refractive surgeons in
the United States in a recent survey conducted by Ophthalmology Times. He is also named as one of the Nation's leading
medical specialists in America's Top Doctors.
|

Paul S. Koch, MD
|
|
Dr. Koch received his MD from Tufts University School of Medicine in 1977. He completed an internship at the Rhode
Island Hospital of Providence in 1978 and completed his residency as Chief Resident at the Manhattan Eye Ear and Throat
Hospital in 1981. Dr. Koch founded Koch Eye Associates in 1981 and serves as it’s Medical Director. He is also the Chief
Medical Editor of Ophthalmology Management. Dr. Koch was one of the first refractive surgeons in America performing
keratomileusis in 1979, keratophakia in 1980, and radial keratotomy in 1983. He has helped popularize many advances in
cataract surgery, including techniques that permit surgery to be performed comfortably without anesthetic injections,
and with vision recovery beginning only a few minutes after the operation is completed. He has won many awards including
the Mericos H. Whittier Foundation's Lifetime Achievement Award and the American Academy of Ophthalmology's Honor Award.
Dr. Koch has written many textbooks on eye surgery, which are the standard reading materials for residency programs in
the US and abroad. He has also written many journal articles, book chapters, and specialty editorials. Dr. Koch has been
named one of the Top 100 Ophthalmologists and one of the Top 15 Cataract Surgeons in North America by Ophthalmology Times
and he has been cited in each issue of the Best Doctors in America.
|

Stephen C. Pflugfelder, MD
|
|
A summa cum laude graduate of Colgate University and SUNY Upstate Medical University Syracuse, Dr. Pflugfelder did his
ophthalmology residency at Baylor College of Medicine. He performed a Cornea fellowship at the Bascom Palmer Eye
Institute of the University of Miami School of Medicine, was appointed to the faculty in 1985 and promoted to Professor
in 1998. In 2000, he joined the faculty of the Baylor College of Medicine's Cullen Eye Institute as a Professor and
Director of the Ocular Surface Center, where he was awarded the James and Margaret Elkins Chair in 2001. He has
published over 140 peer-reviewed articles and over 45 book chapters and monographs, primarily in the field of cornea
diseases and surgery. Dr. Pflugfelder co-edited the textbook: "Dry Eye and Ocular Surface Disorders", published in 2004
and is on the editorial boards of the journals Cornea, American Journal of Ophthalmology, Eye & Contact Lens and The
Ocular Surface. Included in the last three editions of "Best Doctors in America", he received the American Academy of
Ophthalmology Senior Achievement Award in 2000 and a Research to Prevent Blindness Senior Investigator Award in 2002.
Dr. Pflugfelder has served as chairman of the American Academy of Ophthalmology's Lifelong Education for Ophthalmologists
Committee and the Preferred Practice Pattern Committee on Corneal and Ocular Surface diseases. His research interests
include the role of inflammation in dry eye and corneal bioengineering.
View an interview John D. Sheppard, MD
and Stephen C. Pflugfelder, MD on new developments in dry eye treatment and diagnosis
|

John D. Sheppard, MD, MMSc
|
|
Dr. Sheppard received his Masters degree in Medical Science and his MD from Brown University on a full Armed Forces
Health Professions Scholarship. After an internship in pediatrics at the University of Virginia, he spent four years with
the US Navy as 6th Fleet Medical Officer and Chief of Family Practice. He completed his residency in ophthalmology at the
University of Pittsburgh Eye and Ear Institute and a three-year fellowship in corneal diseases, uveitis, third world
blindness, and ocular immunology at the Proctor Research Foundation at the University of California, San Francisco.
In 1989, Dr. Sheppard joined Virginia Eye Consultants and the ophthalmology, microbiology, and immunology faculty of
Eastern Virginia Medical School, where he now serves as Ophthalmology Program Director and Clinical Director of the
Thomas R. Lee Center for Ocular Pharmacology. Dr. Sheppard served as an Associate Examiner for the American Board of
Ophthalmology for 7 years and is now a Mentor examiner. He has participated as principal investigator in over 45 clinical
research trials for major pharmaceutical companies and the FDA. Dr. Sheppard has been the author of over 100 peer review
abstracts, journal articles, and chapters. Dr. Sheppard received the American Academy of Ophthalmology Honor Award in 1995.
View an interview John D. Sheppard, MD
and Stephen C. Pflugfelder, MD on new developments in dry eye treatment and diagnosis
|
Return to top
SBH Optometric Advisory Board

Kenneth Daniels, OD, FAAO
|
|
Kenneth Daniels, OD, FAAO is an Adjunct Assistant Clinical Professor in the Centers
for International Studies. He is a National Eye Institute Clinical Investigator: CLEK (Collaborative
Evaluation of Keratoconus) at the Pennsylvania College of Optometry (Salus University) and was the
Director of Cornea and Contact Lens Research. He enjoys a thriving private practice at Hopewell-
Lambertville Eye Associates in New Jersey. Dr. Daniels is a series editor for an ophthalmic text and
contributing editor to several professional journals. In 2007, he was recognized as one of the future
leaders in the area of Contact Lens and Cornea by the Review of Optometry publication. He is a
nationally and internationally known lecturer and scientific presenter in the areas of contact lens,
refractive surgery, cataract, dry eye, and ocular disease management and treatment and was presented
the 2008 Scientifi c Achievement Award by his colleagues of the New Jersey Society of Optometric
Physicians. Dr. Daniels is the author of “Contact Lens: Basic Bookshelf for Eyecare Practitioners”
(Slack, Inc.) and has authored several book chapters including Contact Lens Correction for
Presbyopia; Contact Lens Care for Post Refractive Surgery; CLIDE: Contact Lens Induced Dry Eye, all
for Slack, Inc. and Contact Lens Related Complications: Atlas of Ophthalmology (Thieme 2009).
|

Paul Karpecki, OD, FAAO
|
|
Dr. Karpecki graduated from Indiana University and completed
a fellowship in Cornea and Refractive Surgery at Hunkeler Eye Centers in affiliation with the
Pennsylvania College of Optometry in 1994. He currently works at the Koffler Vision Group in Cornea
services and Ocular Disease Research. He has lectured in over 400 symposia covering four continents
and was invited to both the Delphi International Society at Wilmer-John’s Hopkins that includes the
top 25 dry eye experts in the world, and the National Eye Institute’s dry eye committee – a task force
established by the U.S. Department of Health and Human Services to better understand and treat dry
eye disease in women. Dr. Karpecki is the current Chair of the Refractive Surgery Advisory Board to
the AOA, Chair of the ASCRS Task Force on the Integrated Eyecare Delivery System and serves on the
AOA Congress Education Committee. A noted educator and author, Dr. Karpecki presently serves on
eight professional journal editorial boards.
View a video of Paul Karpecki talking about ScienceBased Health and HydroEye
|

Jim Owen, OD, FAAO, MBA
|
|
Jim Owen, OD, FAAO, MBA is a graduate of the Illinois College of Optometry and
has a Masters in Business Administration from San Diego State University. He has a private practice
in Encinitas California and is the Optometric Director for Alvarado Eye Associates. He is a Fellow of
the American Academy of Optometry, and a member of the American Optometric Association
(serving on its Refractive Surgery Committee), California Optometric Association and the San Diego
Optometric Society. He is the Immediate Past President of the Optometric Council for Refractive
Therapy and is a member of the Clinical Director Advisory Committee for TLC Laser Eye Centers. Dr.
Owen serves on the editorial board for Optometry Times. He participates in clinical research for
refractive surgery, dry eye and keratoconus and frequently lectures at local and national optometric
meetings on refractive surgery, and anterior segment disease.
|

Peter G. Shaw-McMinn, OD
|
|
Peter G. Shaw-McMinn, OD is an assistant professor of Clinical Studies at the Southern
California College of Optometry. He is the senior partner of Sun City Vision Center, a group practice
including five optometrists. Dr. Shaw-McMinn is a consulting editor to several publications and
co-author of the books Eyecare Business: Marketing and Strategy, Diagnosis and Management of
Computer-Related Vision Problems, and Eyecare Practice Tool Kit. Dr. Shaw-McMinn has served as
chairman of the AOA Practice Management Committee, the Association of Practice Management
Educators, and serves on many advisory boards. He was the appointed Benedict professor in
Practice Management for the University Of Houston College Of Optometry for 2001-2002.
Dr. Shaw-McMinn lectures internationally.
|

Kirk Smick, OD, FAAO
|
|
Kirk Smick, O.D., F.A.A.O. is Chief of Primary Care Services at the Clayton Eye Center in
Atlanta, Georgia. The Clayton Eye Center is a full service eye care facility with eleven ophthalmology
and optometric providers. Dr. Smick is a past president of the Georgia Optometric Association, the
Georgia State Board of Examiners in Optometry and the Southern Council of Optometrists. He is a
frequent lecturer both in the US and abroad, and currently serves as Chairman, Continuing Education
Committee for the American Optometric Association. Dr. Smick graduated from Pacific University
in Forest Grove, Oregon.
|
Return to top

Events
ScienceBased Health exhibits at a number of conferences and meetings throughout the year. Upcoming events:
Optometry's Meeting
AOA (American Optometric Association) 2013 Annual Congress
San Diego Convention Center
San Diego, CA
June 27 - June 29, 2013
Booth 1641 |
Vision Expo West
2013 International Expo and Conference
Sands Convention Center
Las Vegas, NV
October 3 - October 5, 2013
Booth MS5053 |
American Academy of Ophthalmology
2013 Annual Meeting
Ernest N. Morial Convention Center
New Orleans, LA
November 16 - November 19, 2013
Booth 2936 |
|
|
|
|